Published in Biotech Business Week, December 25th, 2006
Mass spectrometry is a tool that is growing in use as the market for tailored drugs and the need to identify biomarkers increases. The completion of the human genome project has ushered in a new era of research focused on the protein products encoded by the genome.
This era will be far more complicated to understand, and will require far more powerful instruments that can...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.